Back to top

Tale of the Tape

Zacks Equity Research

Pfenex (PFNX) Catches Eye: Stock Adds 6.6% in Session
November 17, 2016

CBM PFNX

Trades from $3

Pfenex Inc. (PFNX - Free Report) was a big mover last session, as its shares rose almost 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $7.60 to $10.34 in the past one-month time frame.

Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Pfenex currently carries a Zacks Rank #3 (Hold).

A better-ranked stock in the med-biomed/gene space is Cambrex Corporation (CBM - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is PFNX going up? Or down? Predict to see what others think: Up or Down

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>


In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

CAMBREX CORP (CBM) - free report >>

PFENEX INC (PFNX) - free report >>